Adobe
ADBE
Taiwan Semiconductor
TSM
Apple
AAPL
4
Microsoft
MSFT
5
Meta Platforms
META
US Stock MarketDetailed Quotes
NAGE Niagen Bioscience
- 7.665
- +0.045+0.59%
Trading Apr 29 10:11 ET
595.96MMarket Cap69.68P/E (TTM)
7.685High7.530Low43.40KVolume7.570Open7.620Pre Close329.72KTurnover0.09%Turnover Ratio69.68P/E (Static)77.75MShares9.18052wk High12.93P/B387.90MFloat Cap2.30552wk Low--Dividend TTM50.61MShs Float23.660Historical High--Div YieldTTM2.03%Amplitude0.052Historical Low7.597Avg Price1Lot Size
Niagen Bioscience Key Stats
EPS
According to the latest financial report of Niagen Bioscience, the latest earnings per share (TTM) for the company is 0.09. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Niagen Bioscience's free cash flow? The latest report shows it as 8.51M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Niagen Bioscience shows that the company's current ratio is 3.57, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Niagen Bioscience, the quick ratio is 2.91, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Niagen Bioscience? The latest ROE figure is 17.84%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Niagen Bioscience, the total asset return on investment (ROA) is 11.50%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Niagen Bioscience's latest financial report to see how their gross margin is doing - currently at 62.48%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Niagen Bioscience, the net profit margin is 24.65%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025